Lisdexamfetamine Dimesylate Capsule
Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 64850-552-01
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 888-852-6657
- Availability
- Limited Availability
- Related info
- Estimated recovery: TBD
- Update date
- 11/17/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)
- Company name
- Elite Laboratories, Inc.
- Shortage reason
- Shortage of an active ingredient
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA218604
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer name
- Elite Laboratories, Inc.
- Product NDC
- 64850-552, 64850-550, 64850-551, 64850-553, 64850-554, 64850-555, 64850-556
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- 2d33f701-8067-4a48-98cc-4e7dacaf3cc4
- SPL set ID
- 0e024b69-567c-4b40-9c3e-a2daec34256c
- Package NDC
- 64850-550-01, 64850-551-01, 64850-552-01, 64850-553-01, 64850-554-01, 64850-555-01, 64850-556-01
- UNII
- SJT761GEGS
